1. Chen J.C., Mannino D.M. Worldwide epidemiology of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 1999; 5: 93-99.
2. Mannino D.M., Homa D.M., Akinbami L.J. et al. Chronic obstructive pulmonary disease surveillance - United States, 1971-2000. Morbid. Mortal. Wkly Rep. 2002; 51: 1-16.
3. Pauwels R.A., Rabe K.F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 2004; 364: 613-620.
4. Chapman K.R., Mannino D.M., Soriano J.B. et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur. Respir. J. 2006; 27: 188-207.
5. Stang P., Lydick E., Silberman C. et al. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117 (suppl. 2): 354S-359S.
6. Siafakas N.M., Vermeire P., Pride N.B. et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 1995; 8: 1398-1420.
7. http://www.who.int/respiratory/copd/burden/en/index.html
8. Murray C.J., Lopez A.D. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997; 349: 1498-1504.
9. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2005 (Based On An April 1998 NHLBI/Who Workshop). www.goldcopd.org, aссessed on 20.11.2005.
10. Чучалин А.Г. (ред.) Качество жизни у больных бронхиальной астмой и хронической обструктивной болезнью легких. М.: Издательство "Атмосфера"; 2004.
11. Инфекционное обострение ХОБЛ: практические рекомендации по диагностике, лечению и профилактике. Пособие для врачей. МЗ РФ, РРО, МАКМАХ, 2005. http://www.antibiotic.ru/files/pdf/copd-2005-project.pdf.
12. Rennard S. et al. Impact of COPD in North America and Europe in 2000; subjects' perspective of Confronting COPD International Survey. Eur. Respir. J. 2002; 20: 799-805.
13. Garrido P.C., Diez J.M., Gutierrez J.R. et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health and Quality of Life Outcomes 2006, 4:31 (in press) https://doi.org/10.1186/14777525431.
14. Ferrer M., Alonso J., Morera J. et al. Chronic obstructive pulmonary disease stage and healthrelated quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann. Intern. Med. 1997; 127: 1072-1079.
15. Van der Molen T, Pieters W, Bellamy D, Taylor R. Measuring the success of treatment for chronic obstructive pulmonary disease - patient, physician and health-care payer perspectives. Respir. Med. 2002; 96 (suppl. C): S17-S21.
16. Spencer S., Williams A. The health status burden of exacerbations in COPD measured using the EQ-5D. Eur. Resp. J. 2002; 20 (suppl. 38): 249s.
17. O'Reilly J., Williams A.E., Ledger G., Rice L. Health utility burden for exacerbation of COPD requiring admission into hospital as measured by the EQ-5D. Am. J. Resper. Crit. Care Med. 2003; 167 (suppl. 7): A229.
18. Jones P.W., Quirk F.H., Baveystock C.M. Why quality of life measures should be used in the treatment of patients with respiratory illness. Monaldi Arch. Chest Dis. 1994; 49: 79-82.
19. Ware J.J., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care 1992; 30: 473-483.
20. The EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Hlth Policy 1990; 16: 199-208.
21. Guyatt G.H., Berman L.B., Townsend M. et al. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42: 773-778.
22. Jones P.W., Quirk F.H., Baveystock C.M., Littlejohns P. A selfcomplete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am. Rev. Respir. Dis. 1992; 145: 1321-1327.
23. Spencer S. Calverley P.M.A., Burge P.S et al. оn behalf of the ISOLDE Study Group. Health Status Deterioration in Patients with Chronic Obstructive Pulmonary Disease. Am. J. Respir. Crit. Care Med. 2001; 163: 122-128.
24. Spencer S., Calverley P.M., Burge P.S., Jones P.W. Impact of preventing exacerbations on deterioration of health status in COPD. Eur. Respir. J. 2004; 23: 698-702.
25. Carone M., Ambrosino N., Bertolotti G. et al. Quality of life evaluation and survival study: a 3-yr prospective multinational study on patients with chronic respiratory failure. Monaldi Arch. Chest Dis. 2001; 56: 17-22.
26. Domingo-Salvany A., Lamarca R., Ferrer M. et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2002; 166: 680-685.
27. Oga T., Nishimura K., Tsukino M. et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am. J. Respir. Crit. Care Med. 2003; 167: 544-549.
28. Spencer S., Jones P.W. Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003; 58: 589-593.
29. Almagro P., Calbo E., de Echaguen A.O. et al. Mortality after hospitalization for COPD. Chest 2002; 121: 1441-1448.
30. Osman I.M., Godden D.J., Friend J.A. et al. Quality of life and hospital readmission in patients with chronic obstructive pulmonary disease. Thorax 1997; 52: 6771.
31. Pauwels R.A., Buist A.S., Calverley P.M et al., GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of Chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) workshop summary. Am. J. Respir. Crit. Care Med. 2001; 163: 1256-1276.
32. Celli B.R., MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS / ERS position paper. Eur. Respir. J. 2004; 23: 932-946.
33. Calverley P.M.A., Pauwels R., Vestbo J. et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003; 361: 449-456.
34. Чучалин А.Г., Белевский А.С., Черняк Б.А. и др. Качество жизни больных хронической обструктивной болезнью легких в России: результаты многоцентрового популяционного исследования "ИКАР-ХОБЛ". Пульмонология 2005; 1: 93-102.
35. Wildman M., Groves J., Walia S. Hospitalised COPD exacerbations: survival and univariate outcome predictors, 36 month follow-up. Am. J. Respir. Crit. Care Med. 2002; Vol. 165 (pt. 2): A272.